- Country: Ukraine
- Summary: Ready-To-Use Human Peripheral Blood Lymphocyte Culture Medium (58567 Cell Culture Medium Ivd (In Vitro Diagnostics))
- UAT Ref No: 106950437
- Deadline: 17 Sep 2024
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: UAH 71260
- Notice Type: Tender
- Document Ref. No.: UA-2024-09-09-003583-a
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Medium for cultivation of human peripheral blood lymphocytes, ready to use, 100 ml/vial (58567 Culture medium for IVD cell culture (in vitro diagnostics) 25 pieces, Type: Goods, CPV: ДК 021:2015:24320000-3: Basic organic chemical substances
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINReady-To-Use Human Peripheral Blood Lymphocyte Culture Medium (58567 Cell Culture Medium Ivd (In Vitro Diagnostics)) - Ukraine Tender
The PUBLIC NON-COMMERCIAL ENTERPRISE OF THE KHARKIV REGIONAL COUNCIL "INTER-FIELD SPECIALIZED MEDICAL AND GENETIC CENTER - CENTER FOR RARE (ORPHAN) DISEASES, a Government sector organization in Ukraine, has announced a new tender for Ready-To-Use Human Peripheral Blood Lymphocyte Culture Medium (58567 Cell Culture Medium Ivd (In Vitro Diagnostics)). This tender is published on UkraineTenders under UAT Ref No: 106950437 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-09-17.
The estimated tender value is UAH 71260, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
